Management will initiate the session shortly after the market closes at 4:15 p.m. ET. Following a presentation of the quarterly performance, the company will open the floor for a question-and-answer period. Interested investors are encouraged to register online to receive specific dial-in instructions, though toll-free and international phone lines remain available for those without internet access.
Aethlon Medical Sets August 13 Date for First Quarter Earnings Call
San Diego-based Aethlon Medical will report its fiscal first-quarter financial results on August 13, 2026. The company, which specializes in the Hemopurifier immunotherapeutic device, plans to host a conference call at 4:30 p.m. ET to discuss the figures and provide updates on recent corporate developments.
Aethlon Medical continues to focus on its proprietary lectin-based technology, specifically the Hemopurifier, which holds FDA Breakthrough Device designation for treating advanced metastatic cancer and certain life-threatening viral infections. A replay of the conference call will be accessible on the company website and via designated phone lines starting one hour after the event concludes, remaining available through September 13, 2026.
/aerial-view-of-shanghai-jingan-temple-at-dusk-1034408882-5bdb7c4bc9e77c00268226ca.jpg)
Comments (0)
No comments yet. Be the first!